医院层面连续肾脏替代治疗使用率与危重急性肾损伤患者死亡率的相关性
这项多中心队列研究利用Premier Incorporated AI数据库,纳入美国426家同时提供CKRT和间歇性血液透析的医院中49,685例在ICU接受KRT的危重成人AKI患者。按医院层面CKRT使用率分组,评估其与患者90天全因住院死亡率的校正关联。结果显示,医院CKRT使用率较高(每年KRT患者中CKRT使用≥31.5%)的医院,患者校正死亡概率比使用率较低(<8%)的医院低15%。与医院CKRT使用率第一四分位相比,第三四分位(aHR 0.93,95%CI 0.89-0.98)和第四四分位(aHR 0.85,95%CI 0.81-0.89)与较低的校正住院死亡风险相关,敏感性分析结果一致。
要点
- 在426家美国医院49,685例ICU内接受KRT的危重AKI成人中,医院CKRT使用率较高与患者90天全因住院死亡率较低相关。
- 医院CKRT使用率≥31.5%的医院,患者校正死亡概率比使用率<8%的医院低15%。
- 与医院CKRT使用率第一四分位相比,第三四分位aHR 0.93(95%CI 0.89-0.98),第四四分位aHR 0.85(95%CI 0.81-0.89)。
- 该关联在多项敏感性分析中保持一致。
适用人群与场景
- 美国426家同时提供CKRT和间歇性血液透析的医院中,ICU内因AKI接受KRT的危重成人患者,共49,685例。
研究设计与关键结果
- 多中心队列研究,纳入美国426家医院49,685例ICU内接受KRT的危重AKI成人,按医院层面CKRT使用率分组,评估与90天全因住院死亡率的校正关联。
- 医院CKRT使用率较高(每年KRT患者中CKRT使用≥31.5%)的医院,患者校正死亡概率比使用率较低(<8%)的医院低15%。
- 与医院CKRT使用率第一四分位相比,第三四分位aHR 0.93(95%CI 0.89-0.98),第四四分位aHR 0.85(95%CI 0.81-0.89),与较低的校正住院死亡风险相关。
- findings在多项敏感性分析中保持一致。
证据类型、等级与局限
- 证据类型:多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在需要KRT的危重AKI成人中,于CKRT使用率较高的医院治疗与住院死亡率降低相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: In numerous high-risk medical and surgical conditions, an increased volume of patients and procedures is associated with improved processes and survival. This study examined the association of hospital-level continuous kidney replacement therapy (CKRT) utilization rates with all-cause hospital mortality in critically ill patients with acute kidney injury (AKI).
METHODS: This multicenter cohort study used data from patients admitted to the intensive care unit (ICU) within the Premier Incorporated AI (PINC-AI) database. Patients were critically ill adults with AKI receiving kidney replacement therapy (KRT) in U.S. hospitals that offered both CKRT and intermittent hemodialysis. Hospitals were characterized according to their CKRT utilization in the ICU, and risk-adjusted association with all-cause hospital mortality by day 90 was estimated.
RESULTS: Among 49,685 patients with AKI admitted to 426 acute care U.S. hospitals and treated with KRT in the ICU, a higher hospital-level CKRT utilization rate was associated with lower patient-level risk-adjusted hospital mortality. Hospitals with higher CKRT utilization rates (CKRT use in ≥ 31.5% of KRT patients per year) had a 15% lower adjusted probability of death compared with hospitals with lower CKRT utilization rates (CKRT use in < 8% of KRT patients per year). When compared with the first quartile of hospital-level CKRT use, the third (adjusted hazard ratio [aHR], 0.93, 95%CI: 0.89-0.98) and fourth (aHR, 0.85, 95%CI: 0.81-0.89) quartiles were associated with lower risk-adjusted hospital mortality. Findings were consistent in several sensitivity analyses.
CONCLUSIONS: Among critically ill adults with AKI requiring KRT, treatment in hospitals with higher CKRT utilization rates was associated with reduced hospital mortality.
参考来源
- Neyra JA, Echeverri J, Bronson-Lowe D, et al. Association of hospital-level continuous kidney replacement therapy use and mortality in critically ill patients with acute kidney injury. Intensive Care Med. 2025. PMID: 40586804. doi:10.1007/s00134-025-07993-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。